Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 150,559,392
  • Shares Outstanding, K 2,262,690
  • Annual Sales, $ 26,145 M
  • Annual Income, $ 3,439 M
  • 60-Month Beta 0.67
  • Price/Sales 3.73
  • Price/Cash Flow 15.04
  • Price/Book 2.97
Trade BMY with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 1.37
  • Number of Estimates 6
  • High Estimate 1.39
  • Low Estimate 1.34
  • Prior Year 1.22
  • Growth Rate Est. (year over year) +12.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
60.47 +10.05%
on 01/05/21
66.86 -0.48%
on 01/15/21
+3.97 (+6.34%)
since 12/15/20
3-Month
56.75 +17.24%
on 10/29/20
66.86 -0.48%
on 01/15/21
+6.12 (+10.13%)
since 10/15/20
52-Week
45.76 +45.41%
on 03/23/20
68.34 -2.63%
on 01/22/20
-0.04 (-0.06%)
since 01/15/20

Most Recent Stories

More News
Bristol-Myers Squibb (BMY) Gains As Market Dips: What You Should Know

Bristol-Myers Squibb (BMY) closed the most recent trading day at $66.54, moving +0.79% from the previous trading session.

BMY : 66.54 (+0.79%)
BeiGene (BGNE) Up on Label Expansion of Tislelizumab in China

BeiGene (BGNE) gains following the approval of tislelizumab for the lucrative indication of advanced squamous non-small cell lung cancer in China.

NVS : 95.63 (+1.07%)
BMY : 66.54 (+0.79%)
AMGN : 245.49 (+1.58%)
BGNE : 345.00 (+2.69%)
Lexicon (LXRX) Soars on FDA Permission for Sotagliflozin NDA

Lexicon (LXRX) announces that data from two late-stage studies on its type II diabetes candidate, sotagliflozin, can support a regulatory approval application.

SNY : 49.39 (+0.73%)
BMY : 66.54 (+0.79%)
HALO : 47.43 (+0.81%)
LXRX : 6.87 (-14.66%)
Harpoon's (HARP) Multiple Myeloma Candidate Gets Orphan Drug Tag

Harpoon (HARP) gets Orphan Drug designation by the FDA for HPN217 for the treatment of multiple myeloma.

JNJ : 160.30 (-0.22%)
BMY : 66.54 (+0.79%)
BLUE : 50.53 (-2.55%)
HARP : 23.40 (+9.55%)
PRIME® Study on Real-World Racial Disparities in Multiple Myeloma Care Wins Prestigious William Campbell Felch Award

, /PRNewswire/ -- The Alliance for Continuing Education in the Health Professions has named . This marks the third time PRIME has won the award in the last five years.

ABBV : 110.52 (-0.99%)
BMY : 66.54 (+0.79%)
Global PCOS (Polycystic Ovary Syndrome) Treatment Markets, Forecast & Opportunities, 2025

, /PRNewswire/ -- The report has been added to offering.

ABT : 111.30 (+1.15%)
BAYRY : 15.8200 (-1.37%)
BMY : 66.54 (+0.79%)
MRK : 83.38 (+1.47%)
NVS : 95.63 (+1.07%)
PFE : 36.70 (-0.14%)
TEVA : 11.96 (+4.00%)
Expecting 40% CAGR for Global mHealth Apps Market Size Will Reach USD 105.4 Billion by 2026: Facts & Factors

Facts and Factors have published a new research report titled "mHealth Apps Market By Type (Fitness, Lifestyle Management, Nutrition & Diet, Women's Health, Medication Adherence, Healthcare Providers/...

ABT : 111.30 (+1.15%)
AZN : 51.34 (+0.10%)
BMY : 66.54 (+0.79%)
MRK : 83.38 (+1.47%)
NVS : 95.63 (+1.07%)
Bristol-Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know

Bristol-Myers Squibb (BMY) closed the most recent trading day at $65.43, moving +0.71% from the previous trading session.

BMY : 66.54 (+0.79%)
bluebird (BLUE) to Spin Off Oncology Unit Into Separate Entity

bluebird (BLUE) to separate its severe genetic disease and oncology businesses into different and independent publicly traded companies. Shares up.

BMY : 66.54 (+0.79%)
HALO : 47.43 (+0.81%)
BLUE : 50.53 (-2.55%)
RCUS : 36.98 (-4.76%)
SmarTrend Watching for Potential Pullback in Shares of Bristol-Myer Sqb After 3.72% Gain

Bristol-Myer Sqb (NYSE:BMY) traded in a range yesterday that spanned from a low of $63.24 to a high of $64.83. Yesterday, the shares gained 3.7%, which took the trading range above the 3-day high of...

BMY : 66.54 (+0.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in...

See More

Key Turning Points

3rd Resistance Point 68.41
2nd Resistance Point 67.63
1st Resistance Point 67.09
Last Price 66.54
1st Support Level 65.77
2nd Support Level 64.99
3rd Support Level 64.45

See More

52-Week High 68.34
Last Price 66.54
Fibonacci 61.8% 59.71
Fibonacci 50% 57.05
Fibonacci 38.2% 54.39
52-Week Low 45.76

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar